Page last updated: 2024-09-04

levofloxacin and Cross Infection

levofloxacin has been researched along with Cross Infection in 83 studies

Research

Studies (83)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	44 (53.01)	29.6817
2010's	34 (40.96)	24.3611
2020's	5 (6.02)	2.80

Authors

Authors	Studies
Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M	1
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A	1
Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR	1
Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y	1
Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A	1
Danese, P; DeVito, J; Franceschi, F; Lawrence, L; Sutcliffe, J	1
Laohavaleeson, S; Nicolau, DP; Tessier, PR	1
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC	1
Bulik, CC; Christensen, H; Nicolau, DP	1
Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ	1
Bortolozzo, Lde S; de Castro Siqueira, AM; Jorge, SD; Palace-Berl, F; Pasqualoto, KF; Tavares, LC; Zorzi, RR	1
Brackett, J; Campbell, JR; Davis, A; Foster, CE; Marquez, L; Sauer, HE; Stevens, AM	1
Cheong, HJ; Hyun, H; Kim, WJ; Noh, JY; Seong, H; Song, JY; Yoon, JG	1
Ge, H; Li, N; Yan, L; Zhang, Y	1
Cherabuddi, K; Klinker, KP; Nys, C; Venugopalan, V	1
Bowcock, S; Dawkins, B; Drayson, MT; Dunn, JA; Hawkey, P; Higgins, H; Hulme, CT; Iqbal, G; Low, E; Meads, D; Planche, T; Pratt, G; Raynes, K; Whittaker, AC; Wood, J; Yong, K	1
Ho, CH; Huang, AH; Lai, CH; Lin, HF; Lin, TM; Su, PY	1
Aboshanab, KM; Aboulwafa, MM; Ahmed, MT; Anwer, BE; Mohammed, MA	1
Hsieh, LY; Huang, IW; Lai, JF; Lauderdale, TL; Shiau, YR; Wang, HY; Wu, CJ	1
Clauss, T; Gergs, U; Hofmann, GO; Ihlefeld, D; Neumann, J; Pönicke, K; Weiss, M	1
Ehara, T; Haque, A; Huda, Q; Matsumoto, T; Miah, RA; Ohkusu, K; Okanda, T	1
Nishiura, H; Terahara, F	1
Agnello, M; Bensman, J; Lou, M; Shriner, K; Sullivan, E; Wong-Beringer, A	1
Chang, SW; Chen, PR; Kuo, HY; Liou, ML; Liu, CC; Pien, CJ; Yeh, HW	1
Jia, XQ; Li, YH; Pang, F; Wang, B; Zhao, QG	1
Alba, L; Behta, M; Clock, SA; Della-Latta, P; Furuya, EY; Jenkins, SG; Jia, H; Kubin, CJ; Oliveira, AP; Patel, SJ; Rhee, K; Saiman, L; Schuetz, AN; Weisenberg, SA; Whittier, S; Zhou, JJ	1
Fang, X; Gong, M; Xia, J; Xu, Y; Zhang, D; Zhou, Y	1
Akata, K; Awaya, Y; Chojin, Y; Hara, K; Hata, R; Inoue, N; Ishimoto, H; Kato, K; Kawanami, T; Kawanami, Y; Mukae, H; Naito, K; Nishida, C; Noguchi, S; Obata, H; Oda, K; Ogoshi, T; Orihashi, T; Sasahara, Y; Shimabukuro, I; Shiraishi, T; Suzuki, Y; Tachiwada, T; Takaki, T; Taura, Y; Tokuyama, S; Tsuda, T; Uchimura, K; Yamasaki, K; Yatera, K; Yoshida, Y; Yoshii, C	1
Chen, PC; Huang, W; Kuo, SC; Lai, JF; Lauderdale, TL; Shiau, YR; Wang, HY	1
Eroğlu, C; Günaydın, M; Güney, AK; Karadağ, A; Usta, E; Yanık, K	1
Gautam, V; Kaur, P; Tewari, R	1
Cary, MS; Cluzet, VC; Fishman, NO; Lautenbach, E; Linkin, DR; Morales, KH; Nachamkin, I; Shih, NN	1
Cai, X; Cui, J; Ni, W; Wei, C	1
Chang, SH; Chien, HI; Chien, ST; Hsu, CH; Hsueh, JC; Lee, PL; Lee, TM; Yang, MC; Yang, TF	1
Chan, S; Coulter, MM; Di Pentima, MC; Hossain, J; Rosé, L	1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Bessa, MC; Ferreira, CA; Figueiredo, TP; Gallo, SW; Oliveira, SD; Pagnussatti, VE	1
Eraç, B; Güler, G	1
Al-Hasan, MN; Ereshefsky, BJ; Gokun, Y; Martin, CA	1
Chan, MY; Huang, CY; Hung, WC; Lin, L; Lin, YS; Lu, PL; Sheu, JH; Tseng, SP	1
Cho, SY; Chung, DR; Ha, YE; Kang, CI; Ko, JH; Lee, JY; Lee, NY; Lee, WJ; Park, GE; Peck, KR; Seok, HR; Song, JH	1
Fu, Y; Liu, R; Pan, Z; Zhang, P; Zhou, H; Zhou, J	1
Alvarez Lerma, F; Borges Sá, M; Gracia Arnillas, MP; Grau Cerrato, S; Morón Jiménez, A; Ortiz López, R; Romero Luján, JL	1
Calenda, M; Franco, M; García, C; Passerini de Rossi, B; Vay, C	1
Kozlov, RS; Riabkova, EL	1
Beloborodov, VB	1
Ermertcan, S; Hosgor-Limoncu, M; Tasli, H; Yurtman, AN	1
Chun, CL; Hsueh, PR; Lee, YJ; Lin, YC; Liu, HY; Sun, KL	1
Carratalà, J; Garcia-Vidal, C	1
Blasi, F	1
Petrosillo, N	1
Khawcharoenporn, T; Singh, K; Vasoo, S; Ward, E	1
Hsueh, PR; Lee, YJ; Lin, YC; Liu, HY; Wu, HH	1
Liapikou, A; Torres, A	1
Boulanger, BR; Fogarty, C; Fowler, C; Kahn, JB; Morgan, N; Oross, M; Tennenberg, A; West, M; Wiesinger, B; Wu, SC	1
Baldassarre, M; Brollo, L; Cusenza, A; Di Qual, E; Furlanut, M; Pea, F	1
Arnau, JM; Campany, D; Castells, X; Rigau, D; Vallano, A	1
Gaynes, R; Johnson, TM; Killgore, G; Killum, E; Lowery, HK; Rimland, D; Tenover, FC	1
Alvarez-Lerma, F; Bermejo, B; León, C; Olaechea, P; Palomar, M; Sánchez, M	2
Corrado, M; Drusano, GL; Fowler, C; Kahn, J; Preston, SL; Weisinger, B	1
Naber, KG	1
Cristini, F; Scudeller, L; Viale, P	1
Kollef, MH; Shorr, AF; Susla, GB	1
Jackson, WL; Kollef, MH; Ramage, AS; Shorr, AF; Tennenberg, AM; Wu, SC; Zadeikis, N	1
Bonfiglio, G; Lanzafame, A; Mattina, R; Santini, L	1
Croyle, K; Harrison, LH; Krystofiak, S; Mendelsohn, AB; Muto, CA; Nouri, K; Pasculle, AW; Patel-Brown, S; Paterson, DL; Pokrywka, M; Posey, K; Roberts, T; Saul, M; Shutt, K	1
Chen, WH; Hsueh, PR; Luh, KT	1
Alvarez-Beltrán, M; Alvarez-Lerma, F; Grau, S	1
Davis, NB; Kahn, J; Tennenberg, AM; Wu, SC	1
Bosso, JA; Mauldin, PD	1
Carmeli, Y; Dodds, AE; Engemann, JJ; Kanafani, ZA; Kaye, KS; Weber, SG	1
Bassetti, M; Di Biagio, A; Fasce, R; Mannelli, S; Marchetti, F; Pallavicini, FB; Righi, E; Rosso, R; Viscoli, C	1
Rodríguez, JC; Royo, G; Ruiz, M; Sirvent, E	1
Huijgens, PC; Janssen, JJ; Leidekker, ME; Simoons-Smit, AM; Timmers, GJ; Vandenbroucke-Grauls, CM	1
Biller, P; Brennan, M; Killgore, G; Lind, L; McDonald, LC; Shank, B; Thompson, A; Tkatch, L	1
Angeles Domínguez, M; Carratalà, J; Fernández-Sevilla, A; Gudiol, C; Verdaguer, R	1
Aradhyula, S; Greisnauer, S; Manian, FA; Meyer, PL; Senkel, D; Setzer, J; Wiechens, M	1
Dowzicky, M; Kuti, JL; Nicolau, DP	1
Cohen, C; de Gouveia, L; du Plessis, M; Govender, N; Hoffmann, R; Klugman, KP; Meiring, S; Mpembe, R; Quan, V; Schrag, S; Smith, AM; von Gottberg, A; Whitelaw, A; Wolter, N	1
Gallucci, M; Giobbia, M; Rigoli, R; Scotton, PG; Tonon, E; Vaglia, A	1
Grant, EM; Nightingale, CH; Quintiliani, R	1
Graffunder, EM; Venezia, RA	1

Reviews

11 review(s) available for levofloxacin and Cross Infection

Article	Year
Epidemiology of pathogens and antimicrobial resistance of nosocomial urinary tract infections in patients with spinal cord injuries in China: A systematic review and meta-analysis. The journal of spinal cord medicine, 2023, Volume: 46, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Humans; Levofloxacin; Spinal Cord Injuries; Urinary Tract Infections	2023
[Present aspects and prospects of levofloxacin use in therapy of nosocomial pneumonia]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2008, Volume: 53, Issue:9-10 Topics: Anti-Bacterial Agents; Cross Infection; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial	2008
[Clinical positioning of levofloxacin in the treatment of nosocomial pneumonia]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2008, Volume: 53, Issue:9-10 Topics: Anti-Bacterial Agents; Cross Infection; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial	2008
An update on Legionella. Current opinion in infectious diseases, 2010, Volume: 23, Issue:2 Topics: Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; Community-Acquired Infections; Cross Infection; Germany; Humans; Incidence; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Ofloxacin; United States	2010
[Therapeutic experience with levofloxacin in pneumonia and COPD]. Le infezioni in medicina, 2009, Volume: 17 Suppl 5 Topics: Algorithms; Anti-Bacterial Agents; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Multicenter Studies as Topic; Ofloxacin; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Recurrence; Treatment Outcome	2009
Levofloxacin for the treatment of respiratory tract infections. Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:8 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Treatment Outcome	2012
Levofloxacin in the treatment of urinary tract infections and prostatitis. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16 Suppl 2 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prostatitis; Quinolones; Severity of Illness Index; Treatment Outcome; Urinary Tract Infections	2004
Quinolones for treatment of nosocomial pneumonia: a meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40 Suppl 2 Topics: Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Humans; Imipenem; Levofloxacin; Meta-Analysis as Topic; Ofloxacin; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic	2005
Levofloxacin in the treatment of ventilator-associated pneumonia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12 Suppl 3 Topics: Anti-Infective Agents; Cross Infection; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Respiration, Artificial	2006
Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience. Current medical research and opinion, 2006, Volume: 22, Issue:5 Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Assessment; Risk Factors; Treatment Outcome	2006
Pharmacodynamics and pharmacokinetics of levofloxacin. Chemotherapy, 2000, Volume: 46 Suppl 1 Topics: Anti-Infective Agents; Area Under Curve; Cost-Benefit Analysis; Cross Infection; Drug Costs; Humans; Levofloxacin; Ofloxacin; Streptococcal Infections; Streptococcus pneumoniae	2000

Trials

8 trial(s) available for levofloxacin and Cross Infection

Article	Year
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT. Health technology assessment (Winchester, England), 2019, Volume: 23, Issue:62 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Clostridioides difficile; Cost-Benefit Analysis; Cross Infection; England; Female; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Northern Ireland; Technology Assessment, Biomedical; Wales	2019
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study. Clinical therapeutics, 2003, Volume: 25, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Prospective Studies; Pseudomonas aeruginosa	2003
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia. Clinical pharmacokinetics, 2003, Volume: 42, Issue:6 Topics: Aged; Anti-Infective Agents; Chromatography, High Pressure Liquid; Critical Illness; Cross Infection; Female; Humans; Injections, Intravenous; Intensive Care Units; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Time Factors; Ventilators, Mechanical	2003
Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. The Journal of infectious diseases, 2004, May-01, Volume: 189, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Area Under Curve; Cross Infection; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcus aureus; Treatment Outcome	2004
Levofloxacin in the treatment of pneumonia in intensive care unit patients. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Administration Schedule; Female; Humans; Intensive Care Units; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Treatment Outcome	2004
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40 Suppl 2 Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Cross Infection; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome; Ventilators, Mechanical	2005
Efficacy of the combination of levofloxacin plus ceftazidime in the treatment of hospital-acquired pneumonia in the intensive care unit. International journal of antimicrobial agents, 2006, Volume: 28, Issue:6 Topics: Aged; Anti-Bacterial Agents; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Italy; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Treatment Outcome	2006
Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2007, Volume: 13, Issue:5 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Levofloxacin; Male; Middle Aged; Neutropenia; Ofloxacin; Penicillin V; Treatment Outcome; Viridans Streptococci	2007

Other Studies

64 other study(ies) available for levofloxacin and Cross Infection

Article	Year
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome	2007
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests	2007
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic	2007
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA	2007
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid	2007
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5 Topics: Anti-Infective Agents; Bacteria; Community-Acquired Infections; Cross Infection; Enterococcus; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Respiratory System; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae	2008
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus	2008
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan	2008
In vitro potency of CXA-101, a novel cephalosporin, against Pseudomonas aeruginosa displaying various resistance phenotypes, including multidrug resistance. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Tazobactam; Young Adult	2010
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae	2010
Exploring 5-nitrofuran derivatives against nosocomial pathogens: synthesis, antimicrobial activity and chemometric analysis. Bioorganic & medicinal chemistry, 2014, May-15, Volume: 22, Issue:10 Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cross Infection; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Nitrofurans; Principal Component Analysis; Structure-Activity Relationship	2014
Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow-up for impact on health care-associated infections. Pediatric blood & cancer, 2022, Volume: 69, Issue:7 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Child; Clostridioides difficile; Cross Infection; Delivery of Health Care; Diarrhea; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Retrospective Studies; Sepsis	2022
Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes. PloS one, 2022, Volume: 17, Issue:6 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Healthcare-Associated Pneumonia; Hospitals; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Pseudomonas aeruginosa; Retrospective Studies; Risk Factors	2022
Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:11 Topics: Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination	2019
Extensively drug-resistant Haemophilus influenzae - emergence, epidemiology, risk factors, and regimen. BMC microbiology, 2020, 04-28, Volume: 20, Issue:1 Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Chloramphenicol; Cross Infection; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Incidence; Intensive Care Units; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Taiwan; Trimethoprim, Sulfamethoxazole Drug Combination	2020
Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones. PloS one, 2020, Volume: 15, Issue:8 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Chlorpromazine; Ciprofloxacin; Cross Infection; Diclofenac; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Egypt; Fluoroquinolones; Humans; Levofloxacin; Propranolol	2020
Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan. The Journal of antimicrobial chemotherapy, 2017, Dec-01, Volume: 72, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; DNA Mutational Analysis; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Hospitals; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Middle Aged; Multilocus Sequence Typing; Serotyping; Streptococcal Infections; Streptococcus agalactiae; Taiwan; Young Adult	2017
Population Pharmacokinetics of Levofloxacin in Plasma and Bone of Patients Undergoing Hip or Knee Surgery. Clinical pharmacology in drug development, 2018, Volume: 7, Issue:7 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bone and Bones; Chromatography, High Pressure Liquid; Cross Infection; Female; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies	2018
Characteristics of Resistance Mechanisms and Molecular Epidemiology of Fluoroquinolone-Nonsusceptible Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:10 Topics: Anti-Bacterial Agents; Bangladesh; Cross Infection; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Mutation; Quinolones; Salmonella enterica; Salmonella Infections; Salmonella paratyphi A; Tertiary Care Centers; Typhoid Fever	2018
Fluoroquinolone consumption and Escherichia coli resistance in Japan: an ecological study. BMC public health, 2019, Apr-23, Volume: 19, Issue:1 Topics: Anti-Bacterial Agents; Cross Infection; Databases, Pharmaceutical; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Geography; Humans; Japan; Levofloxacin; Microbial Sensitivity Tests	2019
Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa. Critical care medicine, 2014, Volume: 42, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Cross Infection; Drug Resistance, Microbial; Female; Fluoroquinolones; Hospital Mortality; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Virulence	2014
Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2015, Volume: 48, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Female; Gram-Negative Bacterial Infections; Hospitals; Humans; Levofloxacin; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Respiratory Tract Infections; Risk Factors; Sputum; Stenotrophomonas maltophilia	2015
Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases. Pathologie-biologie, 2014, Volume: 62, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Arthritis, Infectious; beta-Lactam Resistance; beta-Lactamases; China; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Fracture Fixation, Internal; Humans; Infection Control; Klebsiella Infections; Klebsiella oxytoca; Levofloxacin; Male; Meropenem; Middle Aged; Osteitis; Patient Isolation; Protective Clothing; Retrospective Studies; Surgical Wound Infection; Thienamycins; Universal Precautions; Wound Infection	2014
Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units. American journal of infection control, 2014, Volume: 42, Issue:6 Topics: Acinetobacter Infections; Adolescent; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Immunocompromised Host; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Liver Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Time Factors	2014
A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 23 Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Thienamycins	2014
[Efficacy and safety of levofloxacin in patients with nursing and healthcare-associated pneumonia]. The Japanese journal of antibiotics, 2014, Volume: 67, Issue:1 Topics: Anti-Bacterial Agents; Cross Infection; Female; Humans; Japan; Levofloxacin; Male; Ofloxacin; Pneumonia; Prospective Studies	2014
Levofloxacin-resistant haemophilus influenzae, Taiwan, 2004-2010. Emerging infectious diseases, 2014, Volume: 20, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Haemophilus Infections; Haemophilus influenzae; History, 21st Century; Humans; Levofloxacin; Middle Aged; Multilocus Sequence Typing; Public Health Surveillance; Taiwan	2014
[Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates]. Mikrobiyoloji bulteni, 2015, Volume: 49, Issue:1 Topics: Anti-Infective Agents; Ceftazidime; Chloramphenicol; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Integrons; Levofloxacin; Opportunistic Infections; Plasmids; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination	2015
Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India. Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:4 Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; India; Integrons; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Molecular Typing; Polymerase Chain Reaction; Stenotrophomonas maltophilia; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination	2015
Risk factors for gyrA and parC mutations in Pseudomonas aeruginosa. Infection control and hospital epidemiology, 2015, Volume: 36, Issue:4 Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Middle Aged; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin	2015
A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia. Infectious diseases (London, England), 2015, Volume: 47, Issue:12 Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Minocycline; Monte Carlo Method; Moxifloxacin; Pneumonia; Sputum; Stenotrophomonas maltophilia; Tigecycline	2015
Molecular Characterization of Community- and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Isolates in Southern Taiwan. Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Moxifloxacin; Staphylococcal Infections; Taiwan	2015
Trends of fluoroquinolone-resistant Escherichia coli amongst urinary isolates in children: a 10 year surveillance study. Journal of medical microbiology, 2015, Volume: 64, Issue:7 Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Microbial Sensitivity Tests; Urinary Tract Infections	2015
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam	2016
Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital. Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Biofilms; Brazil; Ceftazidime; Chloramphenicol; Cross Infection; Drug Resistance, Bacterial; Fomites; Gene Expression Regulation, Bacterial; Genes, Bacterial; Gram-Negative Bacterial Infections; Hospitals; Humans; Integrons; Levofloxacin; Minocycline; Phylogeny; Plasmids; Polymerase Chain Reaction; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination	2016
[Investigation of fluoroquinolone resistance mechanisms in clinical Acinetobacter baumannii isolates]. Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Fluorometry; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Humans; Indicator Dilution Techniques; Levofloxacin; Microbial Sensitivity Tests; Mutation	2016
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli. Journal of chemotherapy (Florence, Italy), 2017, Volume: 29, Issue:1 Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Critical Illness; Cross Infection; Drug Therapy, Combination; Female; Fluoroquinolones; Gentamicins; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Proportional Hazards Models; Retrospective Studies; Tobramycin; Treatment Outcome	2017
5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii. Marine drugs, 2016, Jul-29, Volume: 14, Issue:8 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anthozoa; Anti-Bacterial Agents; beta-Glucans; Biofilms; Biological Products; Cross Infection; Diterpenes; Drug Resistance, Multiple, Bacterial; Drug Synergism; Equipment Contamination; Extracellular Matrix; Genes, Bacterial; Humans; Levofloxacin; Microscopy, Electron, Scanning	2016
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Intensive Care Units; Length of Stay; Levofloxacin; Male; Middle Aged; Neutropenia; Pseudomonas aeruginosa; Respiratory Tract Infections; Risk Factors; Stenotrophomonas maltophilia; Survival Analysis; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination	2016
Combination of Tigecycline and Levofloxacin for Successful Treatment of Nosocomial Pneumonia Caused by New Delhi Metallo-β-Lactamase-1-Producing Raoultella planticola. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:1 Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Gene Expression; Humans; Levofloxacin; Male; Minocycline; Plasmids; Polymerase Chain Reaction; Sputum; Tigecycline; Treatment Outcome	2017
[Levofloxacin in the treatment of nosocomial infection in critically ill patients]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2008, Volume: 21, Issue:2 Topics: Anti-Bacterial Agents; Critical Illness; Cross Infection; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Retrospective Studies	2008
Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections. International journal of antimicrobial agents, 2009, Volume: 34, Issue:3 Topics: Anti-Infective Agents; Argentina; Biofilms; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Equipment Contamination; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Stenotrophomonas maltophilia	2009
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill. The West Indian medical journal, 2008, Volume: 57, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Synergism; Drug Therapy, Combination; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	2008
Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use. International journal of antimicrobial agents, 2010, Volume: 35, Issue:3 Topics: Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Fluoroquinolones; Hospitals; Humans; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Taiwan	2010
[Experience accumulated in hospital setting with levofloxacin, in monotherapy and in association therapy]. Le infezioni in medicina, 2009, Volume: 17 Suppl 5 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Hospital Departments; Humans; Levofloxacin; Multicenter Studies as Topic; Neoplasms; Neutropenia; Ofloxacin; Practice Guidelines as Topic; Risk Factors; Treatment Outcome	2009
High rates of quinolone resistance among urinary tract infections in the ED. The American journal of emergency medicine, 2012, Volume: 30, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Emergency Service, Hospital; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Quinolones; Retrospective Studies; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult	2012
Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2016
[Use of levofloxacin in the hospital]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2003, Volume: 16, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Utilization; Female; Guideline Adherence; Hospitals, University; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Spain	2003
Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Mar-01, Volume: 38, Issue:5 Topics: Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; Humans; Levofloxacin; Long-Term Care; Microbial Sensitivity Tests; Ofloxacin	2004
[Observational study investigating the use of levofloxacin in ICU patients]. Enfermedades infecciosas y microbiologia clinica, 2004, Volume: 22, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Arrhythmias, Cardiac; Bacterial Infections; Chemical and Drug Induced Liver Injury; Community-Acquired Infections; Comorbidity; Critical Care; Cross Infection; Diarrhea; Drug Resistance; Drug Therapy, Combination; Drug Utilization; Female; Humans; Infusions, Parenteral; Intensive Care Units; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Respiration, Artificial; Respiratory Tract Infections; Spain	2004
Levofloxacin: a suitable option for the infectious disease consultant. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16 Suppl 2 Topics: Anti-Bacterial Agents; Communicable Diseases; Critical Illness; Cross Infection; Humans; Intensive Care Units; Levofloxacin; Ofloxacin; Referral and Consultation; Sensitivity and Specificity	2004
In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens. Chemotherapy, 2005, Volume: 51, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	2005
A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infection control and hospital epidemiology, 2005, Volume: 26, Issue:3 Topics: Anti-Bacterial Agents; Case-Control Studies; Cause of Death; Clindamycin; Clostridioides difficile; Cross Infection; Diarrhea; Disease Outbreaks; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Hospitals, Teaching; Humans; Levofloxacin; Logistic Models; Male; Ofloxacin; Pennsylvania; Retrospective Studies; Risk Factors	2005
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. International journal of antimicrobial agents, 2005, Volume: 26, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan	2005
Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Escherichia coli; Fluoroquinolones; Formularies as Topic; Gatifloxacin; Gram-Negative Bacteria; Humans; Levofloxacin; Methicillin; Methicillin Resistance; Ofloxacin; Pseudomonas aeruginosa; Regression Analysis; Retrospective Studies; Staphylococcus aureus	2006
Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Case-Control Studies; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Levofloxacin; Male; Middle Aged; Ofloxacin; Pseudomonas Infections; Quinolones; Regression Analysis; Retrospective Studies; Risk Factors	2006
[Study investigating the activity of several fluoroquinolones against Pseudomonas aeruginosa using the mutant prevention concentration]. Enfermedades infecciosas y microbiologia clinica, 2006, Volume: 24, Issue:10 Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Genes, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutagenicity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines	2006
Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infection control and hospital epidemiology, 2007, Volume: 28, Issue:2 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Quinolines; Risk Factors	2007
Outbreak of Legionnaires' disease in immunosuppressed patients at a cancer centre: usefulness of universal urine antigen testing and early levofloxacin therapy. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2007, Volume: 13, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antigens, Bacterial; Cancer Care Facilities; Cross Infection; Female; Humans; Immunocompromised Host; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Ofloxacin; Spain	2007
Is it Clostridium difficile infection or something else? A case-control study of 352 hospitalized patients with new-onset diarrhea. Southern medical journal, 2007, Volume: 100, Issue:8 Topics: Aged; Analysis of Variance; Case-Control Studies; Cefazolin; Ceftriaxone; Clostridioides difficile; Confidence Intervals; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Levofloxacin; Male; Missouri; Multivariate Analysis; Odds Ratio; Ofloxacin; Regression Analysis; Retrospective Studies; Risk Factors	2007
A pharmacodynamic simulation to assess tigecycline efficacy for hospital-acquired pneumonia compared with other common intravenous antibiotics. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Cross Infection; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Models, Biological; Monte Carlo Method; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Tigecycline	2008
Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study. Lancet (London, England), 2008, Mar-29, Volume: 371, Issue:9618 Topics: Adolescent; Anti-Bacterial Agents; Antitubercular Agents; Child; Child, Preschool; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; Infant; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Population Surveillance; Rifampin; Risk Factors; South Africa; Statistics, Nonparametric; Streptococcus pneumoniae; Tuberculosis, Multidrug-Resistant; World Health Organization	2008
Rhodococcus equi nosocomial meningitis cured by levofloxacin and shunt removal. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 30, Issue:1 Topics: Actinomycetales Infections; Anti-Infective Agents; Cross Infection; Female; Humans; Levofloxacin; Meningitis, Bacterial; Middle Aged; Ofloxacin; Rhodococcus equi; Ventriculoperitoneal Shunt	2000
Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chi-Square Distribution; Confidence Intervals; Cross Infection; Female; Humans; Length of Stay; Levofloxacin; Logistic Models; Macrolides; Male; Methicillin Resistance; Middle Aged; Odds Ratio; Ofloxacin; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus	2002